Skip to main content

Animations

MJFF Publications

5751 - 5760 of 9117 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013
    Citation Count: 23
  • Summary Details
    OPEN
    Title: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility
    Journal Name: Seizure: European Journal of Epilepsy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003
    Citation Count: 11
  • Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    2022
    Summary Details
    RESTRICTED
    Title: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002
    Citation Count: 15
  • Parkinson's Progression Markers Initiative brain autopsy program
    2022
    Summary Details
    RESTRICTED
    Title: Parkinson's Progression Markers Initiative brain autopsy program
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021
    Citation Count: 11
  • Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    2022
    Summary Details
    RESTRICTED
    Title: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007
    Citation Count: 11
  • Chronotype, sleep, and sleepiness in Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Citation Count: 11
  • The effect of limb selection methods on gait analysis in Parkinson's disease
    2022
    Summary Details
    RESTRICTED
    Title: The effect of limb selection methods on gait analysis in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013
    Citation Count: 2
  • Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    2022
    Summary Details
    RESTRICTED
    Title: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.